Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Recalls Consumer Safety

Consumer Product Recalls: Eye Wash, Chewable Aspirin Recalls

  • News

Executive Summary

OTC eye washes distributed under Family Care, Major and Rugby brands, and HealthA2Z aspirin are recalled.

You may also be interested in...



Podcast: Diversity, Equity, and Inclusion Measures Continue to Evolve in the Clinical Space

Listen to expert perspectives from Tracey Parker, Vice President, Biometrics, Advanced Clinical and Rebecca Starkie, Senior Global Patient Engagement Director, Advanced Clinical on the recent history of DEI in clinical trials and the barriers to patient participation. Examine the key drivers that have influenced the development of diversity, equity, and inclusion programs for clinical trials.

DTA Standardizes Definition Of Digital Therapeutics

Over The Counter 9 June 2023: Embracing AI/AR In Beauty, While Navigating Its Hurdles

In this episode of Over The Counter, HBW Insight speaks to Sampo Parkkinen, CEO and founder of Revieve, a firm that provides businesses with AI technology platforms to deliver a personalized brand experience. We discuss how artificial intelligence and augmented reality continue to shape beauty, where ChatGPT fits in and the importance of consumer privacy.

Table

View full table

Topics

Related Companies

Tags:
Recalls Consumer Safety
Latest Headlines

AMR Alliance Follows Up Global Industry Standard With Responsible Manufacturing Certification

Canadian HTA Ups Industry Fees To Fund Review Process Improvements

Global Pharma Guidance Tracker – May 2023

COVID-19 Has ‘Permanently Changed’ How The EMA Works

See All
UsernamePublicRestriction

Register

PS120206

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By